Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Watson Pharmaceuticals, Inc. (S.D.N.Y. 2011)

See Plans and Pricing

« Back to Dashboard

Pfizer Inc. v. Watson Pharmaceuticals, Inc. (S.D.N.Y. 2011)

Docket   Start Trial Date Filed 2011-06-01
Court District Court, S.D. New York Date Terminated 2015-04-17
Cause 18:1341 Patent Infringement Assigned To Paul Adam Engelmayer
Jury Demand None Referred To
Patents 5,250,534; 5,436,272; 6,469,012
Attorneys Aaron Stiefel; Daniel Peter Dinapoli; Jason A. Nagi; Jeffrey Thomas Martin; Marc Nathan Zubick; Mark Thomas Deming; Soumitra Deka
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc. v. Watson Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Pfizer Inc. v. Watson Pharmaceuticals, Inc. (S.D.N.Y. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-06-01 1 States Patent No. 5,250,534 (the “’534 patent”) with respect to Viagra®, and lists the ’534 patent’s expiration…Defendants for patent infringement of United States Patent No. 6,469,012 (the “’012 patent”). 'l`his… for infringement of its patent: U.S. Patent No, 6,469,012, (the “’012 patent”) titled “Pyrazolopyrimidinones… BACKGROUND The ’012 Patent 13. On October 22, 2002, the United States Patent and Trademark Office (…proceedings, has continued the patentability of claims 1-23, 25, and 26 of the ’012 patent over numerous prior art External link to document
2015-04-17 39 complaint alleging infringement of U.S. Patent No. 6,469,012; and WHEREAS, defendants Watson Pharmaceuticals…2011 17 April 2015 1:11-cv-03721 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.